Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|June 2, 1998
Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapyJ N Waldron, B O'Sullivan, P Warde, et al.Critical Reviews in Immunology|November 19, 2014
Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the artMichael R Olin, G Elizabeth Pluhar, Brian M Andersen, et al.Gerontology & Geriatric Medicine|February 1, 2017
Cardio-Vascular Disease and Cancer: A Dichotomy in Utilization of Clinical Preventive Services by Older Adults in a Developing CountryK Mitchell-Fearon, D Willie-Tyndale, N Waldron, et al.Journal of Health Care for the Poor and Underserved|April 28, 2015
Non-communicable diseases in an older, aging population: a developing country perspective (Jamaica)K Mitchell-Fearon, N Waldron, H Laws, et al.International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
Spinal cord ependymomas: a retrospective analysis of 59 casesJ N Waldron, N J Laperriere, L Jaakkimainen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2000
Carcinoma of the maxillary antrum: a retrospective analysis of 110 casesJ N Waldron, B O'Sullivan, P Gullane, et al.Molecular Cancer Therapeutics|August 25, 2011
Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerNate N Waldron, Dan S Kaufman, Seunguk Oh, et al.The West Indian Medical Journal|September 12, 2013
Validation of the Jamaican Maternal Sexual Role Modelling QuestionnaireM K Hutchinson, T K Smith, N Waldron, et al.Drug Delivery and Translational Research|March 20, 2015
Immunotoxin targeting CD133(+) breast carcinoma cellsJohn R Ohlfest, David M Zellmer, Jayanth Panyam, et al.Gynecologic Oncology|June 1, 2013
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progressionAmy P N Skubitz, Elizabeth P Taras, Kristin L M Boylan, et al.Pageof 7